Open access · CC-BY
via OpenAlex
The Aging Skin–Psoriasis Interface: Could Cellular Senescence and Immunosenescence Slow Therapeutic Response?
Umberto Santaniello, François Rosset, Luca Mastorino, Orsola Crespi, Pietro Quaglino, Simone Ribero
Dermato · 2026 · ▲ 1 citations
Abstract
Elderly psoriasis patients (≥65 years) demonstrate mainly preserved but substantially delayed therapeutic responses to IL-17 and IL-23 inhibitors, achieving lower PASI90 rates at early time-points with eventual “catch-up” by week 52, alongside increased adverse-event-driven discontinuation. This review synthesizes clinical efficacy data from real-world studies with emerging mechanistic evidence on immunosenescence and cellular senescence(definition) to propose the “Inflammatory Noise Floor” hypothesis. We postulate that senescent keratinocytes and fibroblasts constitutively secrete SASP cytokines (IL-6, IL-8, TNF-α) through pathways partially independent of IL-23/IL-17, potentially establishing a persistent baseline inflammation that IL-23/IL-17 blockade might not suppress. Concurrently, immunosenescence, characterized by CD8+CD28− T-cell accumulation, exhaustion marker upregulation, and Treg dysfunction, is hypothesized to impair adaptive immune re-equilibration. This dual mechanism represents one plausible, albeit theoretical, explanatory framework for the temporal lag, PASI plateau effects, and infection risk observed in elderly patients. Optimizing outcomes in the elderly may require a pragmatic approach: accepting stable PASI 75-90 as a successful endpoint and prospectively validating extended assessment timelines. While a direct correlation remains to be proven, this framework identifies cellular and immunosenescence as potential targets for future senotherapeutic interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/dermato6020018
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Santaniello, U., Rosset, F., Mastorino, L., Crespi, O., Quaglino, P., & Ribero, S. (2026). The Aging Skin–Psoriasis Interface: Could Cellular Senescence and Immunosenescence Slow Therapeutic Response?. <em>Dermato</em>. https://doi.org/10.3390/dermato6020018
Vancouver
Santaniello U, Rosset F, Mastorino L, Crespi O, Quaglino P, Ribero S. The Aging Skin–Psoriasis Interface: Could Cellular Senescence and Immunosenescence Slow Therapeutic Response?. Dermato. 2026. doi:10.3390/dermato6020018.
BibTeX
@article{umberto2026TheAgi,
title = {The Aging Skin–Psoriasis Interface: Could Cellular Senescence and Immunosenescence Slow Therapeutic Response?},
author = {Umberto Santaniello and François Rosset and Luca Mastorino and Orsola Crespi and Pietro Quaglino and Simone Ribero},
journal = {Dermato},
year = {2026},
doi = {10.3390/dermato6020018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2019
Preprint · CC-BY
A Single Cell Transcriptomic Atlas Characterizes Aging Tissues in the Mouse
Immunity & Ageing 2022
Open access · CC-BY
The diseased kidney: aging and senescent immunology
2026
Preprint
Molecular and Cellular Mechanisms of Aging: An Integrative Update on the Hallmarks, Emerging Regulators, and Translational Frontiers
University of British Columbia 2024
Open access · US-GOV
Impact 360 Study for Healthy Agers
Anti-Aging Eastern Europe 2026
Open access · CC-BY
CAN HEALTHY LONGEVITY BE ACHIEVED DESPITE ACCELERATED BIOLOGICAL AGING IN INFLAMMATORY RHEUMATIC DISEASES? A GEROSCIENCE-BASED HYPOTHESIS
Assistance Publique - Hôpitaux de Paris 2011
Open access · US-GOV